Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

PCSK9 inhibitors and statin intolerance, pembrolizumab for melanoma, CDC opioid prescribing guideline, and more

PCSK9 inhibitors and statin intolerance, pembrolizumab for melanoma, CDC opioid prescribing guideline, and more

FromJAMA Editors' Summary


PCSK9 inhibitors and statin intolerance, pembrolizumab for melanoma, CDC opioid prescribing guideline, and more

FromJAMA Editors' Summary

ratings:
Length:
9 minutes
Released:
Apr 19, 2016
Format:
Podcast episode

Description

Editor's Audio Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the April 19, 2016 issue
Released:
Apr 19, 2016
Format:
Podcast episode

Titles in the series (100)

Weekly Editors' Audio Summary for JAMA, the Journal of the American Medical Association